Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin for angiomyolipomas in tuberous sclerosis patients
2007-005978-30Phase 4Active
- Sponsor
- Fundació Puigvert
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in angiomyolipoma (AML), tuberous sclerosis complex (TSC) and subependymal giant cell astrocytoma (SEGA), sponsored by Fundació Puigvert. Started Dec 2007; status: active.
02
Drugs
sirolimus
03
Conditions
angiomyolipoma (AML)tuberous sclerosis complex (TSC)subependymal giant cell astrocytoma (SEGA)
Beyond the preview
Go deeper on 2007-005978-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005978-30.